Show simple item record

dc.contributor.authorEsmeijer A
dc.contributor.authorElvers LH
dc.contributor.authorLoeber JG
dc.date.accessioned2012-12-12T18:07:16Z
dc.date.available2012-12-12T18:07:16Z
dc.date.issued1990-11-30
dc.identifier199003004
dc.identifier.urihttp://hdl.handle.net/10029/259069
dc.description.abstractThe TSH-IRMA kit, manufactured by IRE- Medgenix is an immunoradiometric assay for the measurement of thyroid stimulating hormone (TSH) in human serum. This kit was modified and tested for its possible use as routine method in neonatal screening for congenital hypothyroidism (CHT). In the present screeningprocedure TSH is measured in a small (1/4-1/8)-inch bloodspot. For this reason bloodspot calibrators of the 2nd IS for TSH 80/558 were prepared on filterpaper. The minimal detectable dose was 0,010 muU TSH in a (1/4-1/8)-inch bloodspot. There was a good correlation between TSH measured in serum and in bloodspots: "spot" = 1,02 * "serum" + 0,04 (r=0,0988, N=51). The intra- and interassay coefficient of variation was 3.2%, 3.5%, 6.3% and 6.9%, 6.1% 10.2% respectively for bloodspot samples containing 12.2, 19.1 and 29.6 mU/ll serum. In comparison with the current RIA-method used for screening on TSH, this modified IRMA gave better results with respect to analytical performance. The IRMA is also less time consuming than the RIA and can be automated easier. Conclusions: the analytical performance of the IRE- Medgenix TSH-IRMA is very good. The kit, modified for the measurement in bloodspots, can be used in a neonatal CHT screening programme.<br>
dc.description.sponsorshipRIVM
dc.format.extent26 p
dc.language.isonl
dc.publisherRijksinstituut voor Volksgezondheid en Milieu RIVM
dc.relation.ispartofRIVM Rapport 199003004
dc.relation.urlhttp://www.rivm.nl/bibliotheek/rapporten/199003004.html
dc.subject05nl
dc.subjectchtnl
dc.subjectneonatalnl
dc.subjectscreeningnl
dc.subjectimmunoradiometrische assaynl
dc.titleHet gebruik van IRE-Medgenix serum TSH IRMA voor de bepaling van TSH in hielprikbloed van pasgeborenennl
dc.title.alternativeThe use of IRE-Medgenix serum TSH IRMA in neonatal screening for congenital hypothyroidism.en
dc.typeReport
dc.date.updated2012-12-12T18:07:16Z
html.description.abstractThe TSH-IRMA kit, manufactured by IRE- Medgenix is an immunoradiometric assay for the measurement of thyroid stimulating hormone (TSH) in human serum. This kit was modified and tested for its possible use as routine method in neonatal screening for congenital hypothyroidism (CHT). In the present screeningprocedure TSH is measured in a small (1/4-1/8)-inch bloodspot. For this reason bloodspot calibrators of the 2nd IS for TSH 80/558 were prepared on filterpaper. The minimal detectable dose was 0,010 muU TSH in a (1/4-1/8)-inch bloodspot. There was a good correlation between TSH measured in serum and in bloodspots: &quot;spot&quot; = 1,02 * &quot;serum&quot; + 0,04 (r=0,0988, N=51). The intra- and interassay coefficient of variation was 3.2%, 3.5%, 6.3% and 6.9%, 6.1% 10.2% respectively for bloodspot samples containing 12.2, 19.1 and 29.6 mU/ll serum. In comparison with the current RIA-method used for screening on TSH, this modified IRMA gave better results with respect to analytical performance. The IRMA is also less time consuming than the RIA and can be automated easier. Conclusions: the analytical performance of the IRE- Medgenix TSH-IRMA is very good. The kit, modified for the measurement in bloodspots, can be used in a neonatal CHT screening programme.&lt;br&gt;


This item appears in the following Collection(s)

Show simple item record